Showing results (111-120 of 651) with videos related to

Sort By:
Pageof 66
The Breast Journal|September 9, 2009
False negative rate of sentinel lymph node biopsy in multicentric and multifocal breast cancers may be higher in cases with large additive tumor burdenRegina M Fearmonti, Larissa I Batista, Funda Meric-Bernstam, et al.
Journal of Hematology & Oncology|August 3, 2014
Next generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sunitinib (Sutent®) a VEGFR2/PDGFRβ/c-kit/ FLT3/RET/CSF1R inhibitor in a phase II trialVivek Subbiah, Funda Meric-Bernstam, Gordon B Mills, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|August 13, 2008
Building a predictive breast cancer risk modelConstance M Johnson, Joe Ensor, Kristine Broglio, et al.
Annals of Surgical Oncology|November 10, 2010
Impact of progression during neoadjuvant chemotherapy on surgical management of breast cancerAbigail S Caudle, Ana M Gonzalez-Angulo, Kelly K Hunt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2016
Modifying the Clinical Research Infrastructure at a Dedicated Clinical Trials Unit: Assessment of Trial Development, Activation, and Participant AccrualChad Tang, Kenneth R Hess, Dwana Sanders, et al.
Annals of Surgical Oncology|September 21, 2010
Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER databaseMin Yi, Sharon Hermes Giordano, Funda Meric-Bernstam, et al.
Cell|January 9, 2018
Multiclonal Invasion in Breast Tumors Identified by Topographic Single Cell SequencingAnna K Casasent, Aislyn Schalck, Ruli Gao, et al.
Breast Cancer Research : BCR|October 30, 2012
Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancerFunda Meric-Bernstam, Huiqin Chen, Argun Akcakanat, et al.
American Journal of Surgery|April 14, 2009
Margin assessment after neoadjuvant chemotherapy in invasive lobular cancerJamie Wagner, Judy C Boughey, Betsy Garrett, et al.
Annals of Surgical Oncology|November 16, 2023
Axillary Nodal Metastases Conversion and Perioperative Complications with Neoadjuvant Pembrolizumab Therapy in Triple-Negative Breast CancerAshley A Woodfin, Clinton Yam, Mediget Teshome, et al.
Pageof 66